Biortus and XtalPi Announce Strategic Partnership
Wuxi Biortus Biosciences Co., Ltd. (Biortus) and Shenzhen XtalPi Technology Co., Ltd. (XtalPi) reached a strategic partnership agreement on August 26, 2019.
2019
/
08
Since the purchase and arrival of a Biacore S200 on May 2018, our In Vitro Assays and Screening team has been busy with adapting, developing and incorporating the SPR technology into our Assays and Sc
2019
/
07
The Cryo Electron Microscope at Biortus Starts to Shine
In May 2019, the new Tecnai G2 TF20 cryo-electron microscope is up and operational at Biortus. As the first and only CRO company in China with cryo-EM capability, Biortus now offers a better and more
2019
/
06
Research Works Performed at Biortus Are Once Again Published in the World’s Top Journals
On 09 January 2019, the first membrane-associated protein structure solved by Biortus was published in one of the world’s top journal Nature Communications (5-year Impact Factor = 13.691).
2019
/
02
Biortus has passed the on-site verification of active pharmaceutical ingredient (API) Rivastigmine tartrate process development by a listed pharmaceutical company.
2018
/
07
CONTACT US
Telephone：+86 0510-86130005
Adresse：A5, 6 Dongsheng W. Rd., Jiangyin, Jiangsu, China
E-mail：info@biortus.bio
NEWS FEEDS
FOLLOW US
Copyright © 2020 Biortus Biosciences Co.,Ltd. 苏ICP备15024653号-1 Power by www.300.cn